These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 826925)

  • 21. Enhancement of behavioral effect and acute toxicity of methamphetamine by quinine in rats.
    Suzuki T; Fan Chiang HJ; Yanaura S; Yoshida T; Kuroiwa Y
    Jpn J Pharmacol; 1984 Jul; 35(3):273-7. PubMed ID: 6541263
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Juvenile exposure to methamphetamine attenuates behavioral and neurochemical responses to methamphetamine in adult rats.
    McFadden LM; Carter S; Matuszewich L
    Behav Brain Res; 2012 Apr; 229(1):118-22. PubMed ID: 22261020
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The role of D1 and D2 dopamine receptors in oral stereotypy induced by dopaminergic stimulation of the ventrolateral striatum.
    Delfs JM; Kelley AE
    Neuroscience; 1990; 39(1):59-67. PubMed ID: 1982467
    [TBL] [Abstract][Full Text] [Related]  

  • 24. N-oxides of phenothiazine antipsychotics: effects on in vivo and in vitro estimates of dopaminergic function.
    Lewis MH; Widerlöv E; Knight DL; Kilts CD; Mailman RB
    J Pharmacol Exp Ther; 1983 Jun; 225(3):539-45. PubMed ID: 6134814
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Serotonergic and antiserotonergic influences on amphetamine-induced stereotyped behavior.
    Weiner WJ; Goetz C; Westheimer R; Klawans HL
    J Neurol Sci; 1973 Dec; 20(4):373-9. PubMed ID: 4359068
    [No Abstract]   [Full Text] [Related]  

  • 26. The pathophysiology of tardive dyskinesia.
    Klawans HL; Carvey P; Tanner CM; Goetz CG
    J Clin Psychiatry; 1985 Apr; 46(4 Pt 2):38-41. PubMed ID: 2858479
    [TBL] [Abstract][Full Text] [Related]  

  • 27. ["Methamphetamine-stereotypy and hypermotility" in rats chronically treated with reserpine--the effect of intracerebral injection of chlorpromazine].
    Sano H; Totsuka Y; Furuuchi T; Sakai K; Koshikawa N; Shigehara R; Kobayashi M
    Nihon Yakurigaku Zasshi; 1982 Aug; 80(2):113-24. PubMed ID: 6890928
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The NMDA positive modulator D-cycloserine inhibits dopamine-mediated behaviors in the rat.
    Dall'Olio R; Rimondini R; Gandolfi O
    Neuropharmacology; 1994 Jan; 33(1):55-9. PubMed ID: 7910387
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Stereotyped behavioral responses to an auditory stimulus in the course of repeated treatment with methamphetamine plus scopolamine and methamphetamine in rats.
    Yui K; Miura T; Sugiyama K; Ono M; Nagase M
    Nihon Shinkei Seishin Yakurigaku Zasshi; 1994 Jun; 14(3):169-78. PubMed ID: 7941782
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Tolerance to amphetamine in two species (rat and guinea pig) that metabolize it differently.
    Sever PS; Caldwell J; Williams RT
    Psychol Med; 1976 Feb; 6(1):35-42. PubMed ID: 945583
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pharmacological evaluation of clomacran, a new potent psychotropic agent.
    Fowler PJ; Zirkle CL; Macko E; Kaiser C; Sarau H; Tedeschi DH
    Arzneimittelforschung; 1977; 27(4):866-72. PubMed ID: 17419
    [No Abstract]   [Full Text] [Related]  

  • 32. Phenytoin potentiates methamphetamine-induced behavior in mice.
    Izumi K; Nomoto M; Koja T; Shimizu T; Kishita C; Fukuda T
    Pharmacol Biochem Behav; 1984 May; 20(5):803-6. PubMed ID: 6539921
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of continuous administration for 12 months of amine-depleting drugs and chlorpromazine on striatal dopamine function in the rat.
    Hong M; Kilpatrick GJ; Jenner P; Marsden CD
    Neuropharmacology; 1987 Aug; 26(8):1061-9. PubMed ID: 2889161
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Further observations on the effect of repeated electroconvulsive shock on the behavioural responses of rats produced by increases in the functional activity of brain 5-hydroxytryptamine and dopamine.
    Green AR; Heal DJ; Grahame-Smith DG
    Psychopharmacology (Berl); 1977 Apr; 52(2):195-200. PubMed ID: 196304
    [No Abstract]   [Full Text] [Related]  

  • 35. Chronic neonatal blockade of N-methyl-D-aspartate receptor by CGP 39551 increases dopaminergic function in adult rat.
    Dall'Olio R; Facchinetti F; Contestabile A; Gandolfi O
    Neuroscience; 1994 Nov; 63(2):451-5. PubMed ID: 7891857
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparative studies of the effects of chlorpromazine and 5,6-dihydroxytryptamine on locomotion, defensive reactions in the snail Helix lucorum, and command neuron excitability in long-term sensitization.
    Arkhipova SS; Gainutdinova TKh; Ismailova AI; Gainutdinov KhL
    Neurosci Behav Physiol; 2006 Sep; 36(7):759-66. PubMed ID: 16841158
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Impairment of dopaminergic system function after chronic treatment with corticotropin-releasing factor.
    Izzo E; Sanna PP; Koob GF
    Pharmacol Biochem Behav; 2005 Aug; 81(4):701-8. PubMed ID: 16005056
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Phenytoin potentiation of neuroleptic-induced dyskinesias.
    Sethi KD; Hitri A; Diamond BI
    Mov Disord; 1990; 5(4):325-7. PubMed ID: 2147979
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of chronic lithium treatment on dopamine receptors in the rat corpus striatum. II. No effect on denervation or neuroleptic-induced supersensitivity.
    Staunton DA; Magistretti PJ; Shoemaker WJ; Deyo SN; Bloom FE
    Brain Res; 1982 Jan; 232(2):401-12. PubMed ID: 6322915
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Behavioral quantification of striatal dopaminergic supersensitivity after bilateral 6-hydroxydopamine lesions in the mouse.
    Mandel RJ; Wilcox RE; Randall PK
    Pharmacol Biochem Behav; 1992 Feb; 41(2):343-7. PubMed ID: 1574523
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.